Daar I, Yew N, Vande Woude G F
ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, Maryland 21702.
J Cell Biol. 1993 Mar;120(5):1197-202. doi: 10.1083/jcb.120.5.1197.
The relationship between the mos protooncogene protein and cAMP-dependent protein kinase (PKA) during the maturation of Xenopus oocytes was investigated. Microinjection of the PKA catalytic subunit (PKAc) into Xenopus oocytes inhibited oocyte maturation induced by the mos product but did not markedly affect the autophosphorylation activity of injected mos protein. By contrast, PKAc did not inhibit maturation promoting factor (MPF) activation or germinal vesicle breakdown (GVBD) that was initiated by injecting crude MPF preparations. In addition, inhibiting endogenous PKA activity by microinjecting the PKA regulatory subunit (PKAr) induced oocyte maturation that was dependent upon the presence of the endogenous mos product. Moreover, PKAr potentiated mos protein-induced MPF activation in the absence of progesterone and protein synthesis. These data are consistent with the hypothesis that progesterone-induced release from G2/M is regulated via PKAc and that PKAc negatively regulates a downstream target that is positively regulated by mos.
研究了非洲爪蟾卵母细胞成熟过程中mos原癌基因蛋白与环磷酸腺苷依赖性蛋白激酶(PKA)之间的关系。将PKA催化亚基(PKAc)显微注射到非洲爪蟾卵母细胞中,可抑制mos产物诱导的卵母细胞成熟,但对注射的mos蛋白的自磷酸化活性没有明显影响。相比之下,PKAc并不抑制由注射粗制MPF制剂引发的成熟促进因子(MPF)激活或生发泡破裂(GVBD)。此外,通过显微注射PKA调节亚基(PKAr)抑制内源性PKA活性,可诱导依赖于内源性mos产物存在的卵母细胞成熟。此外,在没有孕酮和蛋白质合成的情况下,PKAr增强了mos蛋白诱导的MPF激活。这些数据与以下假设一致:孕酮诱导的从G2/M期释放是通过PKAc调节的,并且PKAc负调节一个由mos正向调节的下游靶点。